Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti IL6R Reduce Complement Serum Level in Rheumatoid Arthritis Patients: Facts and Implications: Monocentric Study in Belgian Center

NCT04505982 is registered in ClinicalTrials.gov with BADOT, Valerie as lead sponsor.

NCT NCT04505982
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505982 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti IL6R Reduce Complement Serum Level in Rheumatoid Arthritis Patients: Facts and Implications: Monocentric Study in Belgian Center
Lead sponsor
BADOT, Valerie
Phase
Observational
Overall status
Unknown status
Start date
July 14, 2020
Completion date
December 31, 2020
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid polyarthritis